Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents

被引:6
|
作者
Hafez, Hend N. [1 ,2 ]
El-Gazzar, Abdel-Rahman B. A. [1 ,2 ]
机构
[1] Imam Mohammad Ibn Saud Islamic Univ IMSIU, Fac Sci, Dept Chem, POB 90950, Riyadh 11623, Saudi Arabia
[2] Natl Res Ctr, Photochem Dept, Heterocycl & Nucleosides Unit, Cairo, Egypt
关键词
Pyridine derivatives; thiazole; pyrazole; imidazole; anticancer activity; HepG2; II INHIBITORY-ACTIVITY; TOPOISOMERASE-I; CYTOTOXICITY; DESIGN;
D O I
10.2174/1570179417666191223163225
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Background: A novel series of pyridine containing 1,3,4-oxa/thiadiazol derivatives 4a,b, pyrazole derivatives 5-7, thiazole derivatives 9a,b and 17a-c, urea derivatives 12a-c, imidiazole derivative 16, imidazo[1,2-a]pyridine derivatives 18a, b, tetrazole 19, pyrane 20 and pyridine derivatives 21 has been synthesized. Objective: This research aims to synthesize 6-(Trifluoromethyl)-2-{[3-(trifluoromethyl)phenyl] amino} nicotinohydrazide 2 and 6-(trifluoromethyl)-2-{[3-(trifluoromethyl)phenyl]amino} pyridin-3-carboaldhyde 15 as key intermediate for the synthesis of novel pyridine derivatives bearing different heterocyclic rings in order to study the additive effect of this ring toward tumor cell lines. Methods: 6-(Trifluoromethyl)-2-{[3-(trifluoromethyl)phenyl]amino} nicotinohydrazide 2 was synthesized in a series of synthetic steps and was used as key intermediate for the synthesis of compounds 3-(1,3,4-oxa/thiadiazol-2-yl)-6-(trifluoromethyl)-N-(3-trifluoromethyl) phenyl) pyridin-2-amine 4a,b, (3,5-dimethyl- 1H-pyrazol-1-yl derivatives) [6-(trifluoromethyl)-2-{[3-trifluoromethyl) phenyl] amino} pyridin-3-yl]methanone 5a,b, 6-8, 9a,b and 12a-c. Also, 6-(trifluoromethyl)-2-{[3-(trifluoromethyl)phenyl]amino} pyridin-3-carboaldhyde (15) was used as a key intermediate for the synthesis of novel series of pyridine derivatives with different heterocyclic ring (16-21). Results: Structures of the newly synthesized compounds were established by elemental analysis and spectral data. All the synthesized compounds were screened for their in vitro anticancer activity against liver cancer (HepG2), human colon cancer (HT-29) and human breast adenocarcinoma cell lines (MCF-7). Conclusion: All the synthesized compounds were investigated for their in vitro antitumor activity. Compounds 4b, 9a,b and 19 showed higher antitumor activity than the doxorubicin. Interestingly, pyridine with pfluorophenyl urea 12a demonstrated the most potent antitumor activity. The activity of these compounds is strongly dependent on the basic skeleton of the molecules and the nature of the heterocyclic ring attached to the pyridine moiety.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 35 条
  • [21] Synthesis, in vitro, and in silico studies of novel poly-heterocyclic compounds bearing pyridine and furan moieties as potential anticancer agents
    Kadi, Ibtissem
    Sekerci, Güldeniz
    Boulebd, Houssem
    Zebbiche, Zineddine
    Tekin, Suat
    Kucukbay, Hasan
    Kucukbay, Fatümetüzzehra
    Boumoud, Taoues
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1271
  • [22] Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX
    Ansari, Mohammad Fawad
    Idrees, Danish
    Hassan, Md. Imtaiyaz
    Ahmad, Kamal
    Avecilla, Fernando
    Azam, Amir
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 544 - 556
  • [23] Design, synthesis, anticancer evaluation, molecular docking, and in silico ADME analysis of novel chalcones incorporated indole-pyrimidine derivatives as promising anticancer agents
    Boddiboyena, Ramesh
    Reddy, G. Nagendra
    Seelam, Nareshvarma
    Sarma, Monima
    Gudisela, Mura reddy
    CHEMICAL DATA COLLECTIONS, 2022, 39
  • [24] Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents
    Xie, Wenlin
    Xie, Shimin
    Zhou, Ying
    Tang, Xufu
    Liu, Jian
    Yang, Wenqian
    Qiu, Minghua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 81 : 22 - 27
  • [25] Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents
    Ghorab, Mostafa M.
    Ragab, Fatma A.
    Heiba, Helmy I.
    Youssef, Hanan A.
    El-Gazzar, Marwa G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (21) : 6316 - 6320
  • [26] Synthesis of novel nicotinohydrazide and (1,3,4-oxadiazol-2-yl)-6-(trifluoromethyl)pyridine derivatives as potential anticancer agents
    Kumar, R. Naresh
    Poornachandra, Y.
    Nagender, P.
    Kumar, G. Santhosh
    Swaroop, D. Krishna
    Kumar, C. Ganesh
    Narsaiah, B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4829 - 4831
  • [27] A straightforward synthesis of potentially biologically active novel urea derivatives from 1,2,3,4-tetrahydronaphthalene-2-carboxylic acids
    Akbaba, Yusuf
    MONATSHEFTE FUR CHEMIE, 2022, 153 (12): : 1251 - 1259
  • [28] Design, synthesis, molecular docking and biological evaluation of novel pyrazole derivatives bearing quinoxalinone moiety as multi-targeted anticancer agents
    Theodore, Cynthia E.
    Anusuya, A. M.
    Sivaiah, G.
    Jain, Ranjana
    Kumar, C. S. Ananda
    Prasad, S. B. Benaka
    Raghu, M. S.
    Alharti, Fahad A.
    Prashanth, M. K.
    Jeon, Byong-Hun
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1288
  • [29] Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents
    Chavva, K.
    Pillalamarri, S.
    Banda, V.
    Gautham, S.
    Gaddamedi, J.
    Yedla, P.
    Kumar, C. G.
    Banda, N.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (21) : 5893 - 5895
  • [30] Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity
    Bashandy, Mahmoud S.
    Al-Said, Mansour S.
    Al-Qasoumi, Saleh I.
    Ghorab, Mostafa M.
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2011, 61 (09): : 521 - 526